157 related articles for article (PubMed ID: 10716915)
1. Effect of growth factors on proliferation of normal, borderline, and malignant breast epithelial cells.
Bhalla V; Joshi K; Vohra H; Singh G; Ganguly NK
Exp Mol Pathol; 2000 Apr; 68(2):124-32. PubMed ID: 10716915
[TBL] [Abstract][Full Text] [Related]
2. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
Karey KP; Sirbasku DA
Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
[TBL] [Abstract][Full Text] [Related]
3. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.
Cullen KJ; Smith HS; Hill S; Rosen N; Lippman ME
Cancer Res; 1991 Sep; 51(18):4978-85. PubMed ID: 1893385
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
6. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
Ram TG; Hosick HL; Ethier SP
J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
8. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
Ethier SP; Mahacek ML; Gullick WJ; Frank TS; Weber BL
Cancer Res; 1993 Feb; 53(3):627-35. PubMed ID: 8425198
[TBL] [Abstract][Full Text] [Related]
9. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
[TBL] [Abstract][Full Text] [Related]
10. Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggered by inhibitors of proliferation in normal and breast cancer epithelial cells.
Lambrecht V; Le Bourhis X; Toillon RA; Boilly B; Hondermarck H
Exp Cell Res; 1998 Dec; 245(2):239-44. PubMed ID: 9851863
[TBL] [Abstract][Full Text] [Related]
11. Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells.
Li Q; Ahmed S; Loeb JA
Cancer Res; 2004 Oct; 64(19):7078-85. PubMed ID: 15466203
[TBL] [Abstract][Full Text] [Related]
12. AP-1 blockade inhibits the growth of normal and malignant breast cells.
Ludes-Meyers JH; Liu Y; Muñoz-Medellin D; Hilsenbeck SG; Brown PH
Oncogene; 2001 May; 20(22):2771-80. PubMed ID: 11420689
[TBL] [Abstract][Full Text] [Related]
13. Differential proliferative response to linoleate in cultures of epithelial cells from normal human breast and fibroadenomas.
Balakrishnan A; Cramer S; Bandyopadhyay GK; Imagawa W; Yang J; Elias J; Beattie CW; Das Gupta TK; Nandi S
Cancer Res; 1989 Feb; 49(4):857-62. PubMed ID: 2643465
[TBL] [Abstract][Full Text] [Related]
14. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
Lehmann W; Widmaier R; Langen P
Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
[TBL] [Abstract][Full Text] [Related]
15. Effect of growth factors on proliferation and expression of growth factor receptors in a human lens epithelial cell line.
Kampmeier J; Baldysiak-Figiel A; de Jong-Hesse Y; Lang GK; Lang GE
J Cataract Refract Surg; 2006 Mar; 32(3):510-4. PubMed ID: 16631066
[TBL] [Abstract][Full Text] [Related]
16. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM
Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194
[TBL] [Abstract][Full Text] [Related]
17. [Growth factors of cultured epithelial cells of breast diseases and breast carcinoma].
Salle V; Souttou B; Magnien V; Israël L; Crépin M
Bull Cancer; 1992; 79(2):133-40. PubMed ID: 1392152
[TBL] [Abstract][Full Text] [Related]
18. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
19. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.
Silvy M; Giusti C; Martin PM; Berthois Y
Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
